BRIDGER MANAGEMENT, LLC - Q2 2022 holdings

$444 Million is the total value of BRIDGER MANAGEMENT, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 44.2% .

 Value Shares↓ Weighting
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$31,935,000
+11.2%
68,159
+29.4%
7.20%
+52.8%
GDDY SellGODADDY INCcl a$31,020,000
-41.3%
445,953
-29.4%
6.99%
-19.4%
CNC SellCENTENE CORP DEL$26,931,000
-9.0%
318,300
-9.5%
6.07%
+25.0%
MS SellMORGAN STANLEY$26,029,000
-20.5%
342,214
-8.6%
5.87%
+9.3%
AZN NewASTRAZENECA PLCsponsored adr$24,882,000376,600
+100.0%
5.61%
CLVT SellCLARIVATE PLC$22,749,000
-26.2%
1,641,319
-10.8%
5.13%
+1.4%
ALC SellALCON AG$21,884,000
-21.9%
313,115
-11.4%
4.93%
+7.3%
VRTX SellVERTEX PHARMACEUTICALS INC$20,591,000
-4.7%
73,072
-11.7%
4.64%
+31.0%
UBER SellUBER TECHNOLOGIES INC$20,323,000
-44.0%
993,309
-2.3%
4.58%
-23.0%
BMRN NewBIOMARIN PHARMACEUTICAL INC$17,220,000207,800
+100.0%
3.88%
HUM NewHUMANA INC$16,382,00035,000
+100.0%
3.69%
CZR SellCAESARS ENTERTAINMENT INC NE$15,770,000
-51.5%
411,753
-2.0%
3.56%
-33.3%
VRSN SellVERISIGN INC$15,688,000
-42.3%
93,753
-23.4%
3.54%
-20.8%
SKIN BuyTHE BEAUTY HEALTH COMPANY$14,078,000
-10.3%
1,094,710
+17.7%
3.17%
+23.2%
IRTC SellIRHYTHM TECHNOLOGIES INC$12,940,000
-48.1%
119,779
-24.4%
2.92%
-28.7%
PSPCU  POST HOLDINGS PARTNERING CORunit 99/99/9999$12,213,000
-1.3%
1,250,0000.0%2.75%
+35.6%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$11,280,000
-19.9%
1,500,0000.0%2.54%
+10.1%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$11,023,000
-5.8%
956,014
+2.8%
2.48%
+29.6%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$10,000,000
+0.3%
1,000,0000.0%2.25%
+37.9%
 AIRSCULPT TECHNOLOGIES INC$9,695,000
-56.7%
1,634,9410.0%2.18%
-40.4%
 WILLIAMS ROWLAND ACQUISITION$9,500,000
+0.3%
950,0000.0%2.14%
+37.9%
PODD NewINSULET CORP$8,936,00041,000
+100.0%
2.01%
POST SellPOST HLDGS INC$8,260,000
-19.2%
100,298
-32.0%
1.86%
+11.0%
FLME  FLAME ACQUISITION CORP$4,895,000
+0.4%
500,0000.0%1.10%
+37.9%
BuyRXSIGHT INC$4,667,000
+89.8%
331,432
+66.9%
1.05%
+161.0%
 BELLRING BRANDS INC$4,657,000
+7.8%
187,1220.0%1.05%
+48.3%
BuyDOCEBO INC$4,309,000
-19.7%
150,300
+44.9%
0.97%
+10.3%
NewR1 RCM INC$3,899,000186,000
+100.0%
0.88%
LIVN BuyLIVANOVA PLC$3,491,000
+9.7%
55,890
+43.7%
0.79%
+50.8%
XENE NewXENON PHARMACEUTICALS INC$2,355,00077,400
+100.0%
0.53%
QTRX BuyQUANTERIX CORP$2,342,000
-13.9%
144,684
+55.3%
0.53%
+18.4%
MSOS  ADVISORSHARES TRpure us cannabis$2,216,000
-50.4%
214,1000.0%0.50%
-31.7%
 SURROZEN INCcl a$2,100,000
-0.3%
700,0010.0%0.47%
+36.7%
ABCM  ABCAM PLCads$2,058,000
-21.0%
142,3500.0%0.46%
+8.7%
SellDERMTECH INC$1,943,000
-64.2%
350,800
-5.0%
0.44%
-50.7%
PRVA SellPRIVIA HEALTH GROUP INC$1,293,000
-62.9%
44,400
-65.9%
0.29%
-49.0%
IMGN SellIMMUNOGEN INC$1,251,000
-47.7%
278,000
-44.6%
0.28%
-28.1%
NAUT  NAUTILUS BIOTECHNOLOGY INC$777,000
-38.0%
289,0000.0%0.18%
-15.0%
VRDN NewVIRIDIAN THERAPEUTICS INC$767,00066,300
+100.0%
0.17%
NEXI  NEXIMMUNE INC$644,000
-61.8%
400,0000.0%0.14%
-47.5%
TECH SellBIO-TECHNE CORP$501,000
-82.7%
1,444
-78.4%
0.11%
-76.2%
 SURROZEN INC*w exp 08/01/203$89,000
-23.9%
466,6660.0%0.02%
+5.3%
 WILLIAMS ROWLAND ACQUISITION*w exp 12/11/202$40,000
-67.7%
475,0000.0%0.01%
-55.0%
MYPSW ExitPLAYSTUDIOS INC*w exp 06/17/202$0-141,105
-100.0%
-0.02%
OLK ExitOLINK HLDG ABsponsored ads$0-45,925
-100.0%
-0.13%
GOOGL ExitALPHABET INCcap stk cl a$0-344
-100.0%
-0.16%
FB ExitMETA PLATFORMS INCcl a$0-4,744
-100.0%
-0.17%
AMZN ExitAMAZON COM INC$0-652
-100.0%
-0.35%
CF ExitCF INDS HLDGS INC$0-24,380
-100.0%
-0.41%
MORF ExitMORPHIC HLDG INC$0-63,700
-100.0%
-0.42%
HCA ExitHCA HEALTHCARE INC$0-20,606
-100.0%
-0.85%
CUTR ExitCUTERA INC$0-83,422
-100.0%
-0.94%
GDS ExitGDS HLDGS LTDsponsored ads$0-150,000
-100.0%
-0.97%
CRM ExitSALESFORCE COM INC$0-33,500
-100.0%
-1.17%
MSGS ExitMADISON SQUARE GRDN SPRT CORcl a$0-42,000
-100.0%
-1.24%
GLPG ExitGALAPAGOS NVspon adr$0-153,700
-100.0%
-1.56%
DG ExitDOLLAR GEN CORP NEW$0-60,900
-100.0%
-2.22%
LKQ ExitLKQ CORP$0-362,987
-100.0%
-2.70%
ROST ExitROSS STORES INC$0-308,168
-100.0%
-4.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Export BRIDGER MANAGEMENT, LLC's holdings